The global oncology market size was valued at USD 222.36 billion in 2023 and is poised to grow from USD 242.15 billion in 2024 to USD 521.60 billion by 2033, growing at a CAGR of 8.9% in the forecast period (2024-2033).
The oncology market is experiencing rapid growth driven by advancements in cancer diagnosis, treatment, and prevention. Oncology, a medical specialty dedicated to addressing cancer, confronts the challenge of abnormal cell proliferation leading to widespread bodily impact.
Key Takeaway:
- - Europe is anticipated to be the most opportunistic market during the forecast period.
- - The cancer treatment segment dominated the oncology market in 2023, garnering a market share of around 57%.
- - The cancer diagnostic segment has accounted 43% of the total market share in 2023
- - The hospitals segment dominated the market in 2023 with a revenue share of 69%
- - Hospital segment is growing at a CAGR of 10.9% from 2024 to 2033.
- - Breast cancer market was valued at USD 60.23 billion in 2023.
The U.S. oncology market size was valued at USD 74.71 billion in 2023 and is anticipated to reach around USD 180.12 billion by 2033, growing at a CAGR of 9.2% from 2024 to 2033.
In Europe, the oncology market emerges as a significant opportunity during the forecast period, driven by a substantial cancer burden affecting the population.
In the oncology market, immunotherapy emerges as the fastest-growing segment, poised for significant expansion during the forecast period. Immunotherapy represents a revolutionary approach to cancer treatment, leveraging the body's own immune system to identify and combat cancer cells effectively. Immunotherapy capitalizes on the advancements in immunology, a branch of science dedicated to understanding the intricacies of the immune system.
In the oncology market, breast cancer emerges as the most opportunistic segment during the forecast period. Globally, breast cancer remains a significant health concern, causing 670,000 deaths in 2022 alone.
https://www.biospace.com/article/releases/laxman-dige-precedenceresearch-com/